Tahir Merchant, Death Row Convict In 1993 Mumbai Blasts, Dies In Hospital

Agencies
April 18, 2018

Mumbai Apr 18:  Tahir Merchant, one of the convicts in the 1993 Mumbai blasts case who was sentenced to death, died at a hospital in Pune early today, a police officer said. Merchant, who was also known as Tahir Takla, was admitted to Sassoon Hospital at 3 am after he complained of chest pain. He died during treatment, the officer said.

"One (1993 Mumbai blasts) convict named Tahir Merchant, who was lodged in the Yerawada prison, was admitted to Sassoon Hospital after he complained of chest pain. However, he died there during treatment around 3:45 am," Dr Bhushankumar Upadhyay, Additional Director General of Prisons Department said.

"Merchant was extradited to India from Abu Dhabi and was arrested by the Central Bureau of Investigation in 2010. He had been serving his jail term in Yerwada central prison in Pune," an officer said.

According to police, Merchant had arranged money to carry out the blasts, and was also linked to conspirators Tiger Memon and Dawood Ibrahim.

In 2007, a special anti-terror TADA court had convicted 100 accused, including actor Sanjay Dutt, in connection with the blasts. In September last year, a special court awarded death sentence to Tahir Merchant and Firoz Khan, while awarding life imprisonment to prime accused Abu Salem and Karimullah Khan in the 1993 Mumbai blasts case.

The court had held that Merchant was amongst the main conspirators.

"The evidence proves the anguish, agitation and frustration expressed by Tahir due to situation prevailing in Bombay during the period of riots in January 1993," it had noted.

He worked with absconding conspirator Tiger Memon, and participated in several conspiracy meetings in Dubai. Tahir made travel arrangements, financed the stay and travel of several co-accused and facilitated their training in Pakistan, the court noted.

"The role of Tahir in conspiracy is prominent. He is one of the initiators of the conspiracy," the court had said in its ruling in June 2017.

Another convict in the case, Mustafa Dossa had died of cardiac arrest at JJ Hospital in Mumbai in June last year. The Mumbai blasts had left 257 people dead and 713 seriously injured. It had destroyed properties worth Rs. 27 crore.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 3,2020

Tehran, Mar 3: Iranian Foreign Minister Javad Zarif on Monday urged Indian authorities to ensure the well-being of all Indians and not let "senseless" violence prevail.

Ministry of External Affairs Spokesperson Raveesh Kumar said on Thursday that law enforcement agencies were working on the ground to prevent violence and ensure restoration of confidence and normalcy.

Mr Kumar has urged international bodies not to make irresponsible statements at this sensitive time. "Iran condemns the wave of organised violence against Indian Muslims. For centuries, Iran has been a friend of India. We urge Indian authorities to ensure the wellbeing of ALL Indians & not let senseless thuggery prevail. Path forward lies in peaceful dialogue and rule of law," Zarif tweeted.

The communal violence over the amended citizenship law in Delhi has claimed at least 42 lives. Frenzied mobs have torched houses, shops, vehicles, a petrol pump and pelted stones at police personnel.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 30,2020

Hyderabad, Jun 30: Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

The Drug Controller General of India - CDSCO, Ministry of Health & Family Welfare granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response. Human clinical trials are scheduled to start across India in July 2020.

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.

The indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.

Announcing the vaccine development milestone, Dr Krishna Ella, Chairman and Managing Director said: "We are proud to announce COVAXIN, India's first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine."

Dr Ella added, "The proactive support and guidance from CDSCO has enabled approvals to this project. Our R&D and Manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform."
Expedited through national regulatory protocols, the company accelerated its objective in completing the comprehensive pre-clinical studies. Results from these studies have been promising and show extensive safety and effective immune responses.

Speaking about Bharat Biotech's prowess, Suchitra Ella, Joint Managing Director said, "Our ongoing research and expertise in forecasting epidemics has enabled us to successfully manufacture a vaccine for the H1N1 pandemic."
"Continuing our focus on creating the only BSL-3 containment facilities for manufacturing and testing in India, Bharat Biotech is committed to advancing vaccine development as a matter of national importance to demonstrate India's strength in handling future pandemics," she added.

Bharat Biotech's track record in developing vero cell culture platform technologies has been proven in several vaccines for Polio, Rabies, Rotavirus, Japanese Encephalitis, Chikungunya and Zika.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 10,2020

New Delhi, Jun 10: Delhi recorded 1,366 fresh cases of COVID-19 on Tuesday, taking the tally to 31,309, while the death toll mounted to 905, authorities said on Wednesday.

According to a health bulletin issued by the Delhi government's health department, there are 18,543 active cases, while 11,861 patients have either recovered, been discharged or migrated.

No health bulletin was issued on Tuesday.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.